Manuscripts and Publications

Filters: Keyword is Female  [Clear All Filters]
Publication
Belzer ME, MacDonell KKolmodin, Clark LF, Huang J, Olson J, Kahana SY, Naar S, Sarr M, Thornton S.  2015.  Acceptability and Feasibility of a Cell Phone Support Intervention for Youth Living with HIV with Nonadherence to Antiretroviral Therapy.. AIDS Patient Care STDS. 29(6):338-45.
Dietz E, Clum GA, Chung S-E, Leonard L, Murphy DA, Perez LV, Harper GW, Ellen JM.  2010.  Adherence to scheduled appointments among HIV-infected female youth in five U.S. cities.. J Adolesc Health. 46(3):278-83.
Philbin MM, Tanner AE, Ma A, Chambers BD, Ware S, Kinnard EN, Hussen SA, Lee S, J Fortenberry D.  2017.  Adolescent and Adult HIV Providers' Definitions of HIV-Infected Youths' Successful Transition to Adult Care in the United States.. AIDS Patient Care STDS. 31(10):421-427.
Alexander AB, Ott MA, Lally MA, Sniecinski K, Baker A, Zimet GD.  2015.  Adolescent decision making about participation in a hypothetical HIV vaccine trial.. Vaccine. 33(11):1331-7.
Mullins TLKowalczy, Zimet G, Lally M, Kahn JA.  2016.  Adolescent Human Immunodeficiency Virus Care Providers' Attitudes Toward the Use of Oral Pre-Exposure Prophylaxis in Youth.. AIDS Patient Care STDS. 30(7):339-48.
Gilbert ALewis, Knopf AS, J Fortenberry D, Hosek SG, Kapogiannis BG, Zimet GD.  2015.  Adolescent Self-Consent for Biomedical Human Immunodeficiency Virus Prevention Research.. J Adolesc Health. 57(1):113-9.
Tanner AE, Philbin MM, Ma A, Chambers BD, Nichols S, Lee S, J Fortenberry D.  2017.  Adolescent to Adult HIV Health Care Transition From the Perspective of Adult Providers in the United States.. J Adolesc Health. 61(4):434-439.
Bruce D, Harper GW, M Fernández I, Jamil OB.  2012.  Age-concordant and age-discordant sexual behavior among gay and bisexual male adolescents.. Arch Sex Behav. 41(2):441-8.
Murphy DA, Chen X, Naar-King S, Parsons JT.  2012.  Alcohol and marijuana use outcomes in the Healthy Choices motivational interviewing intervention for HIV-positive youth.. AIDS Patient Care STDS. 26(2):95-100.
Gamarel KE, Nelson KM, Stephenson R, Rivera OJSantiago, Chiaramonte D, Miller RLin.  2018.  Anticipated HIV Stigma and Delays in Regular HIV Testing Behaviors Among Sexually-Active Young Gay, Bisexual, and Other Men Who Have Sex with Men and Transgender Women.. AIDS Behav. 22(2):522-530.
Nichols SL, Bethel J, Kapogiannis BG, Li T, Woods SP, E Patton D, Ren W, Thornton SE, Major-Wilson HO, Puga AM et al..  2016.  Antiretroviral treatment initiation does not differentially alter neurocognitive functioning over time in youth with behaviorally acquired HIV.. J Neurovirol. 22(2):218-30.
Syed SS, Balluz RS, Kabagambe EK, Meyer WA, Lukas S, Wilson CM, Kapogiannis BG, Nachman SA, Sleasman JW.  2013.  Assessment of biomarkers of cardiovascular risk among HIV type 1-infected adolescents: role of soluble vascular cell adhesion molecule as an early indicator of endothelial inflammation.. AIDS Res Hum Retroviruses. 29(3):493-500.
Boyer CB, Hightow-Weidman L, Bethel J, Li SX, Henry-Reid L, Futterman D, Maturo D, Straub DM, Howell K, Reid S et al..  2013.  An assessment of the feasibility and acceptability of a friendship-based social network recruitment strategy to screen at-risk African American and Hispanic/Latina young women for HIV infection.. JAMA Pediatr. 167(3):289-96.
Saberi P, Neilands TB, Lally MA, Hosek SG, Hightow-Weidman L.  2019.  The Association between Use of Online Social Networks to Find Sex Partners and Sexually Transmitted Infection Diagnosis among Young Men Who Have Sex with Men and Transgender Women Living with HIV.. J Int Assoc Provid AIDS Care. 18:2325958219867324.
Havens PL, Kiser JJ, Stephensen CB, Hazra R, Flynn PM, Wilson CM, Rutledge B, Bethel J, Pan CG, Woodhouse LR et al..  2013.  Association of higher plasma vitamin D binding protein and lower free calcitriol levels with tenofovir disoproxil fumarate use and plasma and intracellular tenofovir pharmacokinetics: cause of a functional vitamin D deficiency? Antimicrob Agents Chemother. 57(11):5619-28.
MacDonell K, Naar-King S, Huszti H, Belzer M.  2013.  Barriers to medication adherence in behaviorally and perinatally infected youth living with HIV.. AIDS Behav. 17(1):86-93.
Dowshen N, Matone M, Luan X, Lee S, Belzer M, Fernandez MIsabel, Rubin D.  2016.  Behavioral and Health Outcomes for HIV+ Young Transgender Women (YTW) Linked To and Engaged in Medical Care.. LGBT Health. 3(2):162-7.
Kahn JA, Rudy BJ, Xu J, Secord EA, Kapogiannis BG, Thornton S, Gillison ML.  2015.  Behavioral, immunologic, and virologic correlates of oral human papillomavirus infection in HIV-infected youth.. Sex Transm Dis. 42(5):246-52.
Willard N, Chutuape K, Stines S, Ellen JM.  2012.  Bridging the gap between individual-level risk for HIV and structural determinants: using root cause analysis in strategic planning.. J Prev Interv Community. 40(2):103-17.
Kahn JA, Xu J, Kapogiannis BG, Sleasman JW.  2017.  Brief Report: Antibody Responses to Quadrivalent HPV Vaccination in HIV-Infected Young Women as Measured by Total IgG and Competitive Luminex Immunoassay.. J Acquir Immune Defic Syndr. 75(2):241-245.
Ruan A, Tobin NH, Mulligan K, Rollie A, Li F, Sleasman J, Aldrovandi GM.  2016.  Brief Report: Macrophage Activation in HIV-Infected Adolescent Males Contributes to Differential Bone Loss by Sex: Adolescent Trials Network Study 021.. J Acquir Immune Defic Syndr. 72(4):372-5.
Steehler K, Siegler AJ.  2019.  Bringing HIV Self-Testing to Scale in the United States: a Review of Challenges, Potential Solutions, and Future Opportunities.. J Clin Microbiol. 57(11)
Sill AM, Kreisel K, Deeds BGriffin, Wilson CM, Constantine NT, Peralta L.  2007.  Calibration and validation of an oral fluid-based sensitive/less-sensitive assay to distinguish recent from established HIV-1 infections.. J Clin Lab Anal. 21(1):40-5.
Reisner SL, Jadwin-Cakmak L, Hughto JMWhite, Martinez M, Salomon L, Harper GW.  2017.  Characterizing the HIV Prevention and Care Continua in a Sample of Transgender Youth in the U.S.. AIDS Behav. 21(12):3312-3327.
Clum GA, Andrinopoulos K, Muessig K, Ellen JM.  2009.  Child abuse in young, HIV-positive women: linkages to risk.. Qual Health Res. 19(12):1755-68.
Li Y, Ni R, Song W, Shao W, Shrestha S, Ahmad S, Cunningham CK, Flynn PM, Kapogiannis BG, Wilson CM et al..  2009.  Clear and independent associations of several HLA-DRB1 alleles with differential antibody responses to hepatitis B vaccination in youth.. Hum Genet. 126(5):685-96.
Mullins TLKowalczy, Lally M, Zimet G, Kahn JA.  2015.  Clinician attitudes toward CDC interim pre-exposure prophylaxis (PrEP) guidance and operationalizing PrEP for adolescents.. AIDS Patient Care STDS. 29(4):193-203.
Havens PL, Hazra R.  2015.  Commentary: The place of tenofovir disoproxil fumarate in pediatric antiretroviral therapy.. Pediatr Infect Dis J. 34(4):406-8.
Boyer CB, Robles-Schrader GM, Li SX, Miller RL, Korelitz J, Price GN, Torres CMRivera, Chutuape KS, Stines SJ, Straub DM et al..  2014.  A comparison of network-based strategies for screening at-risk Hispanic/Latino adolescents and young adults for undiagnosed asymptomatic HIV infection.. J Adolesc Health. 55(6):765-73.
Lee S, Kapogiannis BG, Flynn PM, Rudy BJ, Bethel J, Ahmad S, Tucker D, Abdalian SEllen, Hoffman D, Wilson CM et al..  2013.  Comprehension of a simplified assent form in a vaccine trial for adolescents.. J Med Ethics. 39(6):410-2.
Nichols SL, Lowe A, Zhang X, Garvie PA, Thornton S, Goldberger BA, Hou W, Goodenow MM, Sleasman JW.  2014.  Concordance between self-reported substance use and toxicology among HIV-infected and uninfected at risk youth.. Drug Alcohol Depend. 134:376-382.
Miller RLin, Reed SJ, Francisco VT, Ellen JM.  2012.  Conflict transformation, stigma, and HIV-preventive structural change.. Am J Community Psychol. 49(3-4):378-92.
Reed SJ, Miller RLin.  2013.  Connect to protect and the creation of AIDS-competent communities.. AIDS Educ Prev. 25(3):255-67.
Straub DM, Arrington-Sanders R, D Harris R, Willard N, Kapogiannis B, Emmanuel P, Futterman D, Ellen JM.  2011.  Correlates of HIV testing history among urban youth recruited through venue-based testing in 15 US cities.. Sex Transm Dis. 38(8):691-6.
Tarantino N, Brown LK, Whiteley L, M Fernández I, Nichols SL, Harper G.  2018.  Correlates of missed clinic visits among youth living with HIV.. AIDS Care. 30(8):982-989.
Saberi P, Mayer K, Vittinghoff E, Naar-King S.  2015.  Correlation between use of antiretroviral adherence devices by HIV-infected youth and plasma HIV RNA and self-reported adherence.. AIDS Behav. 19(1):93-103.
Castillo M, Palmer BJ, Rudy BJ, Fernandez MIsabel.  2012.  Creating partnerships for HIV prevention among YMSM: the Connect Protect® Project and House and Ball Community in Philadelphia.. J Prev Interv Community. 40(2):165-75.
Miller RLin, Janulis PF, Reed SJ, Harper GW, Ellen J, Boyer CB.  2016.  Creating Youth-Supportive Communities: Outcomes from the Connect-to-Protect® (C2P) Structural Change Approach to Youth HIV Prevention.. J Youth Adolesc. 45(2):301-15.
Gamarel KE, Nichols S, Kahler CW, Westfall AO, Lally MA, Wilson CM.  2018.  A cross-sectional study examining associations between substance use frequency, problematic use and STIs among youth living with HIV.. Sex Transm Infect. 94(4):304-308.
Sill AM, Constantine NT, Wilson CM, Peralta L.  2010.  Demographic profiles of newly acquired HIV infections among adolescents and young adults in the U.S.. J Adolesc Health. 46(1):93-6.
Tanney MR, Naar-King S, MacDonnel K.  2012.  Depression and stigma in high-risk youth living with HIV: a multi-site study.. J Pediatr Health Care. 26(4):300-5.
Finger JL, Clum GA, Trent ME, Ellen JM.  2012.  Desire for pregnancy and risk behavior in young HIV-positive women.. AIDS Patient Care STDS. 26(3):173-80.
M Fernández I, Hosek S, Warren JC, Jacobs RJ, Hernandez N, Martinez J.  2011.  Development of an easy to use tool to assess HIV treatment readiness in adolescent clinical care settings.. AIDS Care. 23(11):1492-9.
Robles-Schrader GM, Harper GW, Purnell M, Monarrez V, Ellen JM.  2012.  Differential challenges in coalition building among HIV prevention coalitions targeting specific youth populations.. J Prev Interv Community. 40(2):131-48.
Whiteley LB, Brown LK, Swenson R, Kapogiannis BG, Harper GW.  2014.  Disparities in mental health care among HIV-infected youth.. J Int Assoc Provid AIDS Care. 13(1):29-34.
Brown LK, Kennard BD, Emslie GJ, Mayes TL, Whiteley LB, Bethel J, Xu J, Thornton S, Tanney MR, Hawkins LA et al..  2016.  Effective Treatment of Depressive Disorders in Medical Clinics for Adolescents and Young Adults Living With HIV: A Controlled Trial.. J Acquir Immune Defic Syndr. 71(1):38-46.
Castillo-Mancilla J, Seifert S, Campbell K, Coleman S, McAllister K, Zheng J-H, Gardner EM, Liu A, Glidden DV, Grant R et al..  2016.  Emtricitabine-Triphosphate in Dried Blood Spots as a Marker of Recent Dosing.. Antimicrob Agents Chemother. 60(11):6692-6697.
Hosek SG, Lemos D, Harper GW, Telander K.  2011.  Evaluating the acceptability and feasibility of Project ACCEPT: an intervention for youth newly diagnosed with HIV.. AIDS Educ Prev. 23(2):128-44.
Lally M, Goldsworthy R, Sarr M, Kahn J, Brown L, Peralta L, Zimet G.  2014.  Evaluation of an intervention among adolescents to reduce preventive misconception in HIV vaccine clinical trials.. J Adolesc Health. 55(2):254-9.
Ellen JM, Greenberg L, Willard N, Korelitz J, Kapogiannis BG, Monte D, Boyer CB, Harper GW, Henry-Reid LM, Friedman LB et al..  2015.  Evaluation of the effect of human immunodeficiency virus-related structural interventions: the connect to protect project.. JAMA Pediatr. 169(3):256-63.
Brothers J, Harper GW, M Fernández I, Hosek SG.  2014.  EVOLUTION--taking charge and growing stronger: the design, acceptability, and feasibility of a secondary prevention empowerment intervention for young women living with HIV.. AIDS Patient Care STDS. 28(1):33-42.
Boyer CB, Rivera OJSantiago, Chiaramonte DM, Ellen JM.  2018.  Examination of Behavioral, Social, and Environmental Contextual Influences on Sexually Transmitted Infections in At Risk, Urban, Adolescents, and Young Adults.. Sex Transm Dis. 45(8):542-548.
Chutuape KS, Ziff M, Auerswald C, Castillo M, McFadden A, Ellen J.  2009.  Examining differences in types and location of recruitment venues for young males and females from urban neighborhoods: findings from a multi-site HIV prevention study.. J Urban Health. 86(1):31-42.
Boyer CB, Greenberg L, Chutuape K, Walker B, Monte D, Kirk J, Ellen JM.  2017.  Exchange of Sex for Drugs or Money in Adolescents and Young Adults: An Examination of Sociodemographic Factors, HIV-Related Risk, and Community Context.. J Community Health. 42(1):90-100.
Philbin MM, Tanner AE, Duval A, Ellen JM, Xu J, Kapogiannis B, Bethel J, J Fortenberry D.  2014.  Factors affecting linkage to care and engagement in care for newly diagnosed HIV-positive adolescents within fifteen adolescent medicine clinics in the United States.. AIDS Behav. 18(8):1501-10.
Bansal A, Gough E, Ritter D, Wilson C, Mulenga J, Allen S, Goepfert PA.  2006.  Group M-based HIV-1 Gag peptides are frequently targeted by T cells in chronically infected US and Zambian patients.. AIDS. 20(3):353-60.
Murphy DA, Lam P, Naar-King S, D Harris R, Parsons JT, Muenz LR.  2010.  Health literacy and antiretroviral adherence among HIV-infected adolescents.. Patient Educ Couns. 79(1):25-9.
Andrinopoulos K, Clum G, Murphy DA, Harper G, Perez L, Xu J, Cunningham S, Ellen JM.  2011.  Health related quality of life and psychosocial correlates among HIV-infected adolescent and young adult women in the US.. AIDS Educ Prev. 23(4):367-81.
Tanner AE, Philbin MM, Chambers BD, Ma A, Hussen S, Ware S, Lee S, J Fortenberry D.  2018.  Healthcare Transition for Youth Living With HIV: Outcomes from a Prospective Multi-site Study.. J Adolesc Health. 63(2):157-165.
Mullins TLKowalczy, Zimet G, Lally M, Xu J, Thornton S, Kahn JA.  2017.  HIV Care Providers' Intentions to Prescribe and Actual Prescription of Pre-Exposure Prophylaxis to At-Risk Adolescents and Adults.. AIDS Patient Care STDS. 31(12):504-516.
Lally MA, van den Berg JJ, Westfall AO, Rudy BJ, Hosek SG, J Fortenberry D, Monte D, Tanney MR, McFarland EJ, Xu J et al..  2018.  HIV Continuum of Care for Youth in the United States.. J Acquir Immune Defic Syndr. 77(1):110-117.
Philbin MM, Tanner AE, Duval A, Ellen JM, Xu J, Kapogiannis B, Bethel J, J Fortenberry D.  2016.  HIV Testing, Care Referral, and Linkage to Care Intervals Affect Time to Engagement in Care for Newly Diagnosed HIV-Infected Adolescents in 15 Adolescent Medicine Clinics in the United States.. J Acquir Immune Defic Syndr. 72(2):222-9.
Ellen JM, Kapogiannis B, J Fortenberry D, Xu J, Willard N, Duval A, Pace J, Loeb J, Monte D, Bethel J.  2014.  HIV viral load levels and CD4+ cell counts of youth in 14 cities.. AIDS. 28(8):1213-9.
Turnbull EL, A Lopes R, Jones NA, Cornforth D, Newton P, Aldam D, Pellegrino P, Turner J, Williams I, Wilson CM et al..  2006.  HIV-1 epitope-specific CD8+ T cell responses strongly associated with delayed disease progression cross-recognize epitope variants efficiently.. J Immunol. 176(10):6130-46.
Kahn JA, Lee J, Belzer M, Palefsky JM.  2018.  HIV-Infected Young Men Demonstrate Appropriate Risk Perceptions and Beliefs about Safer Sexual Behaviors after Human Papillomavirus Vaccination.. AIDS Behav. 22(6):1826-1834.
Barnes W, D'Angelo L, Yamazaki M, Belzer M, Schroeder S, Palmer-Castor J, Futterman D, Kapogiannis B, Muenz L, D Harris R et al..  2010.  Identification of HIV-infected 12- to 24-year-old men and women in 15 US cities through venue-based testing.. Arch Pediatr Adolesc Med. 164(3):273-6.
Rudy BJ, Kapogiannis BG, Worrell C, Squires K, Bethel J, Li S, Wilson CM, Agwu A, Emmanuel P, Price G et al..  2015.  Immune Reconstitution but Persistent Activation After 48 Weeks of Antiretroviral Therapy in Youth With Pre-Therapy CD4 >350 in ATN 061.. J Acquir Immune Defic Syndr. 69(1):52-60.
Kahn JA, Xu J, Kapogiannis BG, Rudy B, Gonin R, Liu N, Wilson CM, Worrell C, Squires KE.  2013.  Immunogenicity and safety of the human papillomavirus 6, 11, 16, 18 vaccine in HIV-infected young women.. Clin Infect Dis. 57(5):735-44.
Bansal A, Yue L, Conway J, Yusim K, Tang J, Kappes J, Kaslow RA, Wilson CM, Goepfert PA.  2007.  Immunological control of chronic HIV-1 infection: HLA-mediated immune function and viral evolution in adolescents.. AIDS. 21(18):2387-97.
Sayegh CS, MacDonell KK, Clark LF, Dowshen NL, Naar S, Olson-Kennedy J, van den Berg JJ, Xu J, Belzer M.  2018.  The Impact of Cell Phone Support on Psychosocial Outcomes for Youth Living with HIV Nonadherent to Antiretroviral Therapy.. AIDS Behav. 22(10):3357-3362.
Martinez J, Harper G, Carleton RA, Hosek S, Bojan K, Clum G, Glum G, Ellen J.  2012.  The impact of stigma on medication adherence among HIV-positive adolescent and young adult females and the moderating effects of coping and satisfaction with health care.. AIDS Patient Care STDS. 26(2):108-15.
Mehta N, Cunningham CK, Flynn P, Pepe J, Obaro S, Kapogiannis BG, Bethel J, Luzuriaga K.  2010.  Impaired generation of hepatitis B virus-specific memory B cells in HIV infected individuals following vaccination.. Vaccine. 28(21):3672-8.
J Fortenberry D, Koenig LJ, Kapogiannis BG, Jeffries CL, Ellen JM, Wilson CM.  2017.  Implementation of an Integrated Approach to the National HIV/AIDS Strategy for Improving Human Immunodeficiency Virus Care for Youths.. JAMA Pediatr. 171(7):687-693.
Murphy DA, Hoffman D, Seage GR, Belzer M, Xu J, Durako SJ, Geiger M.  2007.  Improving comprehension for HIV vaccine trial information among adolescents at risk of HIV.. AIDS Care. 19(1):42-51.
Naar-King S, Parsons JT, Murphy DA, Chen X, D Harris R, Belzer ME.  2009.  Improving health outcomes for youth living with the human immunodeficiency virus: a multisite randomized trial of a motivational intervention targeting multiple risk behaviors.. Arch Pediatr Adolesc Med. 163(12):1092-8.
Mullins TLK, Rudy BJ, Wilson CM, Sucharew H, Kahn JA.  2013.  Incidence of sexually transmitted infections in HIV-infected and HIV-uninfected adolescents in the USA.. Int J STD AIDS. 24(2):123-7.
Jaspan HB, Cunningham CK, Tucker TJP, Wright PF, Self SG, Sheets RL, Rogers AS, Bekker L-G, Wilson CM, Duerr A et al..  2008.  Inclusion of adolescents in preventive HIV vaccine trials: public health policy and research design at a crossroads.. J Acquir Immune Defic Syndr. 47(1):86-92.
Outlaw AY, Naar-King S, Tanney M, Belzer ME, Aagenes A, Parsons JT, Merlo LJ.  2014.  The initial feasibility of a computer-based motivational intervention for adherence for youth newly recommended to start antiretroviral treatment.. AIDS Care. 26(1):130-5.
Brick LAnn D, Nugent NR, Kahana SY, Bruce D, Tanney MR, M Fernández I, Bauermeister JA.  2018.  Interaction Effects of Neighborhood Disadvantage and Individual Social Support on Frequency of Alcohol Use in Youth Living with HIV.. Am J Community Psychol. 61(3-4):276-284.
Hightow-Weidman L, Muessig K, Claude K, Roberts J, Zlotorzynska M, Sanchez T.  2020.  Maximizing Digital Interventions for Youth in the Midst of Covid-19: Lessons from the Adolescent Trials Network for HIV Interventions.. AIDS Behav. 24(8):2239-2243.
Chutuape KS, Willard N, Sanchez K, Straub DM, Ochoa TN, Howell K, Rivera C, Ramos I, Ellen JM.  2010.  Mobilizing communities around HIV prevention for youth: how three coalitions applied key strategies to bring about structural changes.. AIDS Educ Prev. 22(1):15-27.
Gamarel KE, Nelson KM, Heinze J, Chiaramonte DM, Miller RL.  2019.  The moderating role of resilience resources in the association between crime exposure and substance use among young sexual minority men.. Subst Use Misuse. 54(11):1787-1798.
Naar-King S, Outlaw AY, Sarr M, Parsons JT, Belzer M, MacDonell K, Tanney M, Ondersma SJ.  2013.  Motivational Enhancement System for Adherence (MESA): pilot randomized trial of a brief computer-delivered prevention intervention for youth initiating antiretroviral treatment.. J Pediatr Psychol. 38(6):638-48.
Tanney MR, Naar-King S, Murphy DA, Parsons JT, Janisse H.  2010.  Multiple risk behaviors among youth living with human immunodeficiency virus in five U.S. cities.. J Adolesc Health. 46(1):11-6.
Naar-King S, Parsons JT, Murphy D, Kolmodin K, D Harris R.  2010.  A multisite randomized trial of a motivational intervention targeting multiple risks in youth living with HIV: initial effects on motivation, self-efficacy, and depression.. J Adolesc Health. 46(5):422-8.
Dinaj-Koci V, Wang B, Naar-King S, MacDonell KKolmodin.  2019.  A Multi-Site Study of Social Cognitive Factors Related to Adherence Among Youth Living With HIV in the New Era of Antiretroviral Medication.. J Pediatr Psychol. 44(1):98-109.
Bruce D, Kahana SY, Bauermeister JA, Nichols SL, Hightow-Weidman LB, Heinze JE, Shea J, M Fernández I.  2015.  Neighborhood-level and individual-level correlates of cannabis use among young persons living with HIV/AIDS.. Drug Alcohol Depend. 151:173-80.
Nichols SL, Bethel J, Garvie PA, Patton DE, Thornton S, Kapogiannis BG, Ren W, Major-Wilson H, Puga A, Woods SP.  2013.  Neurocognitive functioning in antiretroviral therapy-naïve youth with behaviorally acquired human immunodeficiency virus.. J Adolesc Health. 53(6):763-71.
Trent M, Chung S-E, Ellen JM, Clum G.  2007.  New sexually transmitted infections among adolescent girls infected with HIV.. Sex Transm Infect. 83(6):468-9.
Mulligan K, D Harris R, Monte D, Stoszek S, Emmanuel P, Hardin DS, Kapogiannis BG, Worrell C, Meyer WA, Sleasman J et al..  2010.  Obesity and dyslipidemia in behaviorally HIV-infected young women: Adolescent Trials Network study 021.. Clin Infect Dis. 50(1):106-14.
Wilson EC, Iverson E, Garofalo R, Belzer M.  2012.  Parental support and condom use among transgender female youth.. J Assoc Nurses AIDS Care. 23(4):306-17.
Straub DM, Deeds BGriffin, Willard N, Castor J, Peralta L, Francisco VT, Ellen J.  2007.  Partnership selection and formation: a case study of developing adolescent health community-researcher partnerships in fifteen U.S. communities.. J Adolesc Health. 40(6):489-98.
Rudy BJ, Murphy DA, D Harris R, Muenz L, Ellen J.  2009.  Patient-related risks for nonadherence to antiretroviral therapy among HIV-infected youth in the United States: a study of prevalence and interactions.. AIDS Patient Care STDS. 23(3):185-94.
Dempsey AG, Macdonell KE, Naar-King S, Lau C-Y.  2012.  Patterns of disclosure among youth who are HIV-positive: a multisite study.. J Adolesc Health. 50(3):315-7.
Coy KC, Hazen RJ, Kirkham HS, Delpino A, Siegler AJ.  2019.  Persistence on HIV preexposure prophylaxis medication over a 2-year period among a national sample of 7148 PrEP users, United States, 2015 to 2017.. J Int AIDS Soc. 22(2):e25252.
Kiser JJ, Fletcher CV, Flynn PM, Cunningham CK, Wilson CM, Kapogiannis BG, Major-Wilson H, Viani RM, Liu NX, Muenz LR et al..  2008.  Pharmacokinetics of antiretroviral regimens containing tenofovir disoproxil fumarate and atazanavir-ritonavir in adolescents and young adults with human immunodeficiency virus infection.. Antimicrob Agents Chemother. 52(2):631-7.
Baheti G, Kiser JJ, Havens PL, Fletcher CV.  2011.  Plasma and intracellular population pharmacokinetic analysis of tenofovir in HIV-1-infected patients.. Antimicrob Agents Chemother. 55(11):5294-9.
Gross IMoses, Hosek S, Richards MHeather, M Fernández I.  2016.  Predictors and Profiles of Antiretroviral Therapy Adherence Among African American Adolescents and Young Adult Males Living with HIV.. AIDS Patient Care STDS. 30(7):324-38.
Outlaw AY, Naar-King S, Janisse H, Parsons JT.  2010.  Predictors of condom use in a multisite study of high-risk youth living with HIV.. AIDS Educ Prev. 22(1):1-14.
Macdonell KE, Naar-King S, Murphy DA, Parsons JT, Harper GW.  2010.  Predictors of medication adherence in high risk youth of color living with HIV.. J Pediatr Psychol. 35(6):593-601.

Pages